The Development of an Animal Model of Glioma for Use in Experimental Neuro-oncology

References

• Schold S C, Jr., Bigner D D. A review of animal brain tumor models that have been used for therapeutic studies. Oncology of the Nervous System, M D Walker. Martinus Nijhoff, Boston 1983; 31–63
   Google Scholar
• Wilson C B. Brain tumor models for experimental therapy. Biology of Brain Tumors, O D Laerum, D D Bigner, M F Rajewsky. UICC Technical Report Series, Geneva 1978; Vol 30: 185–99
   Google Scholar
• Wilson C B, Bates E A. Transplantable brain tumors. The Experimental Biology of Brain Tumors, W M Kirsch, E G Paoletti. Charles C Thomas, Springfield 1972; 19–56
   Google Scholar
• Fraser H. Spontaneous astrocytoma in mice and its transmission with viable cells. Animal Models of Neurological Disease, F Clifford Rose, P O Behan. Pitman, London 1980; 393–404
   Google Scholar
• Pilkington G J, Darling J L, Lantos P L. Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization. J Neurol Sci 1983; 62: 115–39
   PubMedGoogle Scholar
• Pilkington G J, Darling J L, Lantos P L. Tumori-genicity of cell lines (VMDk) derived from a spontaneous murine astrocytoma. Histology, fine structure and immunocytochemistry of tumours. J Neurol Sci 1985; 71: 145–64
   PubMedGoogle Scholar
• Bradford R, Darling J L, Thomas D GT. The in vitro and in vivo chemosenstivity of VMDk murine astrocytoma cell lines. J Neuro-Oncol 1986; 4: 113
   Google Scholar
• Bradford R, Darling J L, Thomas D GT. Heterogeneity in chemosensitivity and acquisition of drug resistance in a murine model of glioma. Brain Oncology, Biology, Diagnosis and Therapy, M Chatel, F. Darcel, J Pecker. Martinus Nijhoff, Dordrecht 1987; 363–7
   Google Scholar
• Bradford R, Darling J L, Thomas D GT. The development of a therapeutic model of glioma and its response to the nitrosoureas BCNU and CCNU. J Neurol Neurosurg Psychiatry 1987; 49: 128
   Google Scholar
• Patel A J, Hunt A, Tahourdin C SM. Regional development of glutamine synthetase activity in the rat brain and its association with the differentiation of astrocytes. Develop Brain Res 1983; 8: 31–7
   Google Scholar
• Serrano R D, Pegram C N, Bigner D D. Tumorigenic cell culture lines from a spontaneous VM/DK murine astrocytoma (SMA). Acta Neuropath (Berl) 1980; 51: 53–64
   PubMedGoogle Scholar
• Polak J M, Van Noorden S. Immunocytochemistry. Wright, Bristol 1983; 11–42
   Google Scholar
• Steel G G. Growth kinetics of tumours. Oxford University Press, Oxford 1977
   Google Scholar
• Bradley N J, Bloom H JG, Davies A JS. Growth of human gliomas in immune-deficient mice: a possible model for pre-clinical therapy studies. Br J Cancer 1978; 38: 263–72
   PubMed Web of Science ®Google Scholar
• Weir M D, Hunt A, Patel A J. Comparison between induction of glutamine synthestase by removal of glutamine and by addition of glucocorticoids in normal astrocytes and in astroglioma cells. Biochem Soc Trans 1984; 12: 805–6
   Google Scholar
• Fraser H. Astrocytomas in an inbred mouse strain. J Path 1971; 103: 266–70
   PubMedGoogle Scholar
• Pilkington G J, Darling J L, Lantos P L. Evaluation of a transplantable mouse brain tumour: a model for the study of human glioma. Biology of Brain Tumour, M D Walker, D GT Thomas. Martinus Nijhoff, Boston 1986; 153–60
   Google Scholar
• Lloyd H H. Estimation of tumor cell kill from Gom-pertz growth curves. Cancer Chemother Rep 1975; 59: 267–77
   PubMedGoogle Scholar
• Antonitus D S, Choi B H, Lapham L W. Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein. Brain Res 1975; 89: 363–7
   PubMedGoogle Scholar
• Schachner M, Schoonmaker G, Hynes P O. Cellular and subcellular localization of LETS protein on the nervous system. Brain Res 1978; 158: 149–58
   PubMedGoogle Scholar
• Vaheri A, Ruoslahti E., Westermark B. A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med 1976; 143: 64–72
   PubMed Web of Science ®Google Scholar
• Hynes R O. Cell surface proteins and malignant transformation. Biochim Biophys Acta 1976; 458: 73–107
   PubMed Web of Science ®Google Scholar
• Vaheri A, Mosher D F. High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta 1978; 516: 1–25
   PubMed Web of Science ®Google Scholar
• Yamada K M, Olden K. Fibronectins: adhesive glycoproteins of cell surface and blood. Nature 1978; 275: 179–84
   PubMed Web of Science ®Google Scholar
• Pilkington G J, Lantos P L, Darling J L. Three cell lines from a spontaneous murine astrocytoma show variation in astrocytic differentiation. Neurosci Lett 1982; 34: 315–20
   PubMedGoogle Scholar
• Der C J, Stanbridge E J. Alterations in the extracellular matrix organization associated with the reexpression of tumorigenicity in human cell hybrids. Int J Cancer 1980; 26: 451–9
   PubMedGoogle Scholar
• Paetau A, Mellstrom K, Westermark B. Mutually exclusive expression of fibronectin and glial fibrillary acid protein in cultured brain cells. Exp Cell Res 1980; 129: 337–44
   PubMed Web of Science ®Google Scholar
• Jones T R, Ruoslahti E, Schold S C. Fibronectin (FN) and glial fibrillary acidic protein (GFAP) expression in human anaplastic gliomas (HGL) grown in athymic ‘nude’ mice. J Neuropath Exp Neurol 1980; 39: 365
   Google Scholar
• Jones T R, Rouslahti E, Schold S C. Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res 1982; 42: 168–77
   PubMedGoogle Scholar
• Norenberg M D. The distribution of glutamine synthetase in the rat central nervous system. J Histochem Cytochem 1979; 27: 756–62
   PubMed Web of Science ®Google Scholar
• Norenberg M D, Martinez-Hernandez A. A fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979; 161: 303–10
   PubMed Web of Science ®Google Scholar
• Koppel H, Hunt A, Patel A J. Studies on glutamine synthetase (GS) and glial fibrillary protein (GFAP) in primary cultures of astroglial cells. Neuropath Appl Neurobiol 1985; 11: 76
   Google Scholar
• Pilkington G J, Lantos P L. The role of glutamine synthetase in the diagnosis of cerebral tumours. Neuropath Appl Neurobiol 1982; 8: 227–36
   PubMedGoogle Scholar
• Koppel H, Martin J M, Pilkington G J. Heterogeneity of a cultured neoplastic glial line: establishment and characterisation of six clones. J Neurol Sci 1986; 76: 295–315
   PubMedGoogle Scholar
• Ausman J I, Shapiro W R, Rail D P. Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res 1970; 30: 2394–400
   PubMed Web of Science ®Google Scholar
• Jones T R, Bigner S H, Schold S C, Jr. Anaplastic human gliomas grown in athymic mice: morphology and glial fibrillary acidic protein expression. Am J Path 1981; 105: 316–27
   PubMedGoogle Scholar
• Vick N, Khandekar J D, Bigner D D. Chemotherapy of brain tumours: the ‘blood brain barrier’ is not a factor. Arch Neurol 1977; 34: 523–6
   PubMed Web of Science ®Google Scholar
• Tator C H. Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. J Neurosurg 1972; 37: 1–8
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Allen N, Clendenon N. An improved rat brain-tumor model. J Neurosurg 1980; 53: 808–815
   PubMedGoogle Scholar
• Pires M, Pilkington G J. Vascular permeability differences related to morphological features in extracranial and intracerebral components of experimental murine gliomas [Abstract]. 5th Annual Meeting. British Glioma Group, 1985
   Google Scholar
• Wassenaar W, Tator C H, So W S. The development of an intracerebral glioma model for brain tumor chemotherapy. J Neurosurg 1973; 39: 293–301
   PubMedGoogle Scholar
• Rama B, Spoerri O, Holzgraefe M. Current brain tumour models with particular consideration of the transplantation techniques: outline of literature and personal preliminary results. Acta Neurochir 1986; 79: 35–41
   PubMedGoogle Scholar
• Geran R I, Congleton G F, Dudeck L E. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Cancer Chemother Rep (Part 2) 1974; 4: 53–87
   PubMedGoogle Scholar
• Allen N. Experimental therapy of brain tumors. Neurochemistry and Clinical Neurology, L Battistin, G Hashim, A Lajtha. A. R. Liss, New York 1980; 441–54
   Google Scholar
• Shapiro W R. The chemotherapy of intracerebral vs subcutaneous murine gliomas: a comparative study of the effect of VM 26. Arch Neurol 1974; 30: 222–6
   PubMedGoogle Scholar